Bluejay Diagnostics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $1,449 |
Gross Profit | -53 | -54 | 1,392 |
EBITDA | -1,795 | -2,373 | -2,364 |
EBIT | -1,848 | -2,428 | -2,420 |
Net Income | -2,475 | -2,328 | -2,302 |
Net Change In Cash | 0 | 0 | 1,449 |
Free Cash Flow | -1,858 | -2,596 | -2,865 |
Cash | 8,058 | 2,661 | 2,208 |
Basic Shares | 483 | 294 | 154 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $249 | $ | $0 |
Gross Profit | -780 | 48 | -145 | -157 |
EBITDA | -9,172 | -8,990 | -3,084 | -1,039 |
EBIT | -9,953 | -9,296 | -3,230 | -1,196 |
Net Income | -9,953 | -9,227 | -3,729 | -1,125 |
Net Change In Cash | 0 | 249 | 0 | |
Free Cash Flow | -9,018 | -8,940 | -4,390 | -508 |
Cash | 2,208 | 10,114 | 19,047 | 912 |
Basic Shares | 137 | 126 | 125 | 79 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$7.75 |
2024-06-30 | -$256.16 |
2024-03-31 | -$7.89 |
2023-12-31 | -$1.86 |
